Alto Neuroscience announces interim analysis from ALTO-300 trial
Alto Neuroscience (ANRO) announced a “favorable” outcome from the planned interim analysis for the Phase 2b trial of ALTO-300 as an adjunctive ...
QHSLab and Town Total Compounding Announce Strategic Co-Marketing Partnership to Expand Market Opportunities and Drive Organic Growth
Expanding market reach to drive organic revenue growth without equity dilutionCollaborating with AI-driven health assessments and customized ...